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 Case Report 
 During routine follow-up of a nodu-
lar melanoma on the right shoulder, a 
66-year-old woman presented a conspicu-
ously linear arrangement of pigmented 
macules on her left calf. She reported that 
2 years earlier, she had suffered from a lin-
ear and very superficial bloodless skin ero-
sion at the same spot, resulting from fric-
tion with the lining of a ski boot during 
skiing in the Swiss Alps, which had healed 
within a few days without leaving any re-
sidual structural damage. In the subse-
quent weeks, however, pigmented macules 
had developed at the line of the erosion. 
Her skin type was Fitzpatrick II and she 
had  1 50 nevus cell nevi on the whole in-
tegument. She did not recall any past in-
tensive sunburn on her legs. Within her 
family, several members had multiple 
atypical moles and her brother had devel-
oped a melanoma.
 Clinical examination (fig. 1a) and der-
matoscopy (fig. 1b) of the left calf showed 
multiple, linearly arranged pigmented 
macules up to 5 mm in diameter. The le-
sions had a regular, reticular architecture 
with symmetry of pattern. In vivo confo-
cal microscopy (fig. 1c, d) revealed pig-
ment in the basal layer of the epidermis 
and dermal junction. There was no sign of 
malignancy (no plump bright cells, no 
dendritic or pagetoid cells within the epi-
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 Abstract 
 The mechanisms for the development of ac-
quired melanocytic nevi remain mostly un-
clear. Here we report a case of eruptive nevi 
that developed after localized superficial 
trauma, and review the currently known cel-
lular and triggering factors for acquired me-
lanocytic nevi. A 66-year-old woman pre-
sented a linear arrangement of pigmented 
macules on her left calf that developed after 
a bloodless skin erosion on the same spot, 
resulting from friction with the lining of a ski 
boot. Dermatopathology identified multi-
ple junctional proliferations of single or 
small nest-forming melanocytes with bridg-
ing, pigment incontinence and moderate 
cellular atypia. The number of a person’s 
nevi correlates with age, race and genetics, 
but blistering diseases, scarring processes, 
light exposure and immunosuppression can 
contribute to nevocellular growth as well. 
Damaged keratinocytes and inflammatory 
cells can release growth factors inducing ne-
vus cell proliferation, and immunosuppres-
sion could end cellular surveillance keeping 
preexisting nevus cell nests in check. We 
conclude that in predisposed patients, the 
trigger for eruptive nevi can be reduced to a 
simple localized minor trauma. 
 Copyright © 2010 S. Karger AG, Basel 
 Received: August 10, 2009 
 Accepted after revision: January 2, 2010 
 Published online: April 24, 2010 
 Alexander A. Navarini 
 Department of Dermatology,  University Hospital of Zurich
Gloriastrasse 31 
 CH–8091 Zurich (Switzerland) 
 Tel. +41 44 255 11 11, Fax +41 44 255 45 49, E-Mail alexander.navarini   @   usz.ch 
 © 2010 S. Karger AG, Basel
1018–8665/10/2204–0291$26.00/0 
 Accessible online at:
www.karger.com/drm 
dermis). There had been no preexisting le-
sion in the area where the nevi developed. 
Dermatopathology (fig. 1e) of one of the 
macules identified mostly junctional pro-
liferation of single or small nest-forming 
melanocytes with bridging, pigment in-
continence and moderate cellular atypia.
 Review of the Literature 
 Melanocytic nevi are benign prolifera-
tions of a type of melanocyte defined as a 
‘nevus cell’  [1] . They are highly prevalent 
and dynamic lesions. There are 2 subtypes 
to be differentiated: Congenital melano-
cytic nevi are present at birth, have life-
long persistence and represent hamarto-
mas probably due to a postzygotic distur-
bance. Acquired melanocytic nevi instead 
include all benign melanocytic neoplasia 
occurring after birth. This group is quite 
diverse and consistent clinical and histo-
pathological criteria are still lacking  [2] . 
Although their cellular pathogenesis is 
clear in respect of their development from 
so-called nevus cells or altered melano-
cytes, the actual mechanisms causing 
them to appear or wane again over time 
mostly remain unclear  [3, 4] .
 Nevus cells and melanocytes are 
thought to stem from melanoblasts in the 
neural crest  [5] , which are formed from 
specific cells residing at the junction be-
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tween the surface ectoderm and the neural 
plate. The signaling proteins Wnt3a and 
Wnt1 promote the development of neural 
crest progenitors in pigment cells rather 
than neuronal cells  [6] . Wnt1 promotes ex-
pansion of melanoblasts in a paracrine 
manner. Canonical Wnt signaling then 
leads to activation of the melanocyte
master regulator microphthalmia-asso-
ciated transcription factor  [7] which in-
creases typical melanocyte antigens such 
as MART1 and GP100  [8] .
 Melanoblasts are further characterized 
by high expression of transcription factor 
SOX10, the tyrosinase kinase receptor 
KIT, G-coupled receptor EDRNB and me-
lanogenic enzyme DCT  [9] . They migrate 
over considerable distances from the neu-
ral crest to the epidermis, starting approx-
imately 1 day later than other neural-crest-
derived cells such as cartilage, central
nervous system and smooth muscle cell 
precursors. Although the exact mecha-
nisms responsible for the complicated mi-
gration pattern are not understood yet, it 
appears that cadherins, integrins and ex-
tracellular signaling pathways operating 
through EDRNB are involved  [10, 11] . On 
the way to the target tissues, they start to 
express tyrosinase, the rate-limiting en-
zyme for melanin synthesis, and finally 
take up residence at the dermal-epidermal 
junction as mature, melanin-positive me-
lanocytes.
 How many of these cells represent me-
lanocyte stem cells (MSC) is not clear yet. 
It is known that there is more than one 
MSC niche in the skin: the bulge of the
hair follicle, the interfollicular epidermis 
and possibly the sebaceous glands. All 
these MSC populations have different 
characteristics, i.e. within the bulge of the 
hair follicle mostly undifferentiated mela-
noblasts are found  [12] . Several factors 
(microphthalmia-associated transcription 
factor, Pax3, SOX10 and DCT) combine to 
maintain the MSC in a complex interplay. 
It is not known whether nevus cells and the 
resulting acquired melanocytic nevi are 
formed by melanocytes or MSC.
 Nevus cells are different from normal 
melanocytes in 2 ways. They cluster to 
nests in the lower epidermis or upper der-
mis, while normal melanocytes are single 
cells in the basal layer of the epidermis. 
The second difference is that nevus cells 
(with the exception of blue nevus cells) do 
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 Fig. 1.  a Overview of the left calf of the pa-
tient. Dotted line indicates magnified area 
in  b .  b Dermatoscopic view of the linearly 
arranged pigmented patches shows uni-
formly fine reticulated pattern. Dotted 
line indicates area analyzed with confocal 
microscopy and histology. Magnification 
 ! 10.  c Confocal microscopy capture of
the basal cell layer of the lesion. White col-
or reflects supranuclear melanin caps of 
small round bright keratinocytes, giving a 
cobblestone appearance.  d Confocal mi-
croscopy capture of the superficial dermo-
epidermal junction zone shows bright
dermal papillary rings composed of a
layer of monomorphic bright cells (so-
called edged papillae).  e Hematoxylin-eo-
sin stained biopsy, showing pigmented ke-
ratinocytes, isolated nevus cell nests in the 
upper dermis as well as some pigment in-
continence. 
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not have dendritic processes  [13] .  These 
nevus cells can proliferate within the epi-
dermis, producing junctional nevi. Unna’s 
theory of downward migration was put 
forward in 1893  [14] to explain the evolu-
tion of nevi. It holds that increased num-
bers of melanocytes at the dermoepider-
mal junction (lentigo simplex and junc-
tional nevus) eventually form nevus nests 
(compound nevus) and later translocate 
completely in the dermis as dermal nevi. 
However, Unna’s theory cannot explain 
several features of nevi such as maturation, 
infiltration of adnex structures, infiltra-
tion in the deep dermis and neuroid dif-
ferentiation  [2] . Therefore, Cramer  [15] put 
forth the theory of upward migration that 
is more adapted to explain histopathologic 
features. It states that nevus cells can re-
side in the dermis and migrate upwards. 
At the end of the day, however, both theo-
ries might be incomplete and probably me-
lanocytes and nevus cells can migrate in 
both directions and even horizontally  [2] .
 It is not clear whether the clinical defi-
nition of nevi as readily visible cellular ag-
gregates encompasses all nevoid prolifera-
tions or just the few largest ones that are 
identified upon examination of the integ-
ument. Are the sites of macroscopic nevi 
the only regions where nevus cells have 
lodged themselves and proliferated? Ap-
parently, this might not be the case, as a 
recent work has shown that dermatoscopi-
cally, small nests of nevus cells can be pres-
ent all over the integument in children 
 [16] . If this finding indicates that everyone 
of us harbors myriads of clinically invisi-
ble nevus nests all over the integument, it 
would mean that not nevus cell migration 
but triggering factors make the difference 
whether an acquired nevus develops or 
not.
 Physical and Temporal Factors 
 The observation of newly forming ac-
quired melanocytic nevi, eruptive or not, 
in association with specific triggering fac-
tors has been made many times ( table 1 ). 
The identification of such triggering fac-
tors contributing to the development of 
melanocytic nevi is of great interest and 
has not yet been completed.
 It is known that the prevalence of ac-
quired melanocytic nevi correlates with a 
person’s age, race and genetics. A Scottish 
study showed that in the first decade of 
life, an average of 2–3 melanocytic nevi 
can be found on the whole integument. 
This number rises to 22–33 nevi in the 
third decade and sinks again to 4–6 nevi 
in the seventh decade  [17] . Whether the 
reduction in the number reflects a spon-
taneous involution of nevi, was not ad-
dressed in the study. Both the parents’ 
number of nevi and the Fitzpatrick skin 
type can influence the number of a per-
son’s nevi.
 However, next to these static factors 
that are not easily influenced by external 
factors, blistering  [18] or scarring process-
es  [19] as well as light exposure  [20, 21] 
have been shown to contribute to nevus 
development. How could these various sit-
uations induce nevus growth? In all 3, 
some local cellular damage in keratino-
cytes and other cells occurs, releasing or 
triggering induction of growth factors that 
could act on melanocytes.
 It has been shown that damaged kera-
tinocytes can release cytokines such as   -
MSH  [22] that could influence nevus cells 
to form larger nests and macroscopically 
visible nevi. Regarding nevus development 
after bullous disease, it has been pro-
posed that either melanocytic hyperpla-
sia accompanies keratinocytic prolifera-
tion during the healing phase of bullae  [23, 
24] or that cells of a preexisting nevus re-
siding within the bulla could be spread 
Light exposure
Sun exposure leading to multiple or severe 
sunburns
Intermittent intense sun exposure (e.g. on 
sunny holidays)
Chronic moderate sun exposure (e.g. 
residence at lower latitudes)
Psoralen and UVA therapy (PUVA)1
Neonatal phototherapy
Severe sunburn1
Cutaneous injury
Minor trauma (present case)
Köbner phenomenon [50]
Bullous disease
Erythema multiforme1
Toxic epidermal necrolysis/Stevens-
Johnson syndrome1
Epidermolysis bullosa – junctional 
(particularly generalized atrophic 
benign) > recessive dystrophic > 
recessive simplex1
Bullae secondary to sulfur mustard gas 
exposure1
Scarring processes
Lichen sclerosus2
Systemic immunosuppression
Chemotherapy, particularly for childhood 
hematologic malignancies1–3
Allogeneic bone marrow transplantation3
Solid organ transplantation, particularly 
renal1, 3
HIV infection/AIDS1
Chronic myelogenous leukemia1
Internal malignancy1
Anti-tumor necrosis factor therapy 
(infliximab, etanercept)1, 3
Alefacept1
Azathioprine1
Prednisolone1
Methotrexate1
6-Mercaptopurine1
Increased hormone levels
Pregnancy1, 4
Growth hormone (increased size, not 
number, of nevi)
Addison disease1
Thyroid hormone1
Other
Atopic dermatitis in children (conflicting 
results in different studies)
Postoperative fever1
Seizures or electroencephalographic 
abnormalities1
Idiopathic1
A dapted from Bovenschen et al. [47] and Bolognia et al. [51].
1 Eruptive nevi have been reported.
2 An increased number of atypical nevi may also be seen.
3 Nevi have a predilection for the palms and soles.
4 Relative immunosuppression may also play a role; an increase in the size or number 
of nevi has not been clearly demonstrated for pregnant women in general.
Table 1.  Triggers for the development and/or growth of melanocytic nevi
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within the area of the bulla and set them-
selves down to form nests, leading to sub-
sequent enlargement of the nevus. In addi-
tion, relevant concentrations of interleu-
kin 8 (IL-8), basic fibroblast growth factor, 
human hepatocyte growth factor, GM-
CSF, leukotriene B4 and prostaglandin E2 
were identified within bullae, possibly 
contributing to melanocytic growth  [25] .
 Cellular Factors 
Nevus cells depend on several growth 
factors, among them basic fibroblast 
growth factor  [26] . Binding of the high-
affinity receptor FGF-R1 results in cell 
proliferation  [27] . Basic fibroblast growth 
factor and FGFR-1 are expressed in 55 and 
67% of the melanocytic nevi, respectively 
 [28] . Other factors  [29] required by me-
lanocytes and nevus cells are insulin,
  -MSH and (for cell culture) 12-O-tetra-
decanoyl-phorbol-13-acetate, which gives 
the melanocytic cells a selective growth 
advantage.
Alpha-melanocyte-stimulating hor-
mone (also called   -melanotropin or   -
MSH) is derived from pro-opiomelano-
cortin. It stems from the intermediate lobe 
of the pituitary gland but can be released 
ectopically by several cell types including 
melanocytes. In normal melanocytes,   -
MSH can induce melanogenesis and pro-
liferation. Interestingly, it also enhances 
melanocyte adhesion to fibronectin  [30] .
 Transforming growth factor   and its 
receptor EGFR have been implicated as 
important growth factors for melanoma 
 [31, 32] . Normal melanocytes can express 
transforming growth factor   after UV ir-
radiation  [33] – therefore, it could have a 
role in inducing melanocytic prolifera-
tion, i.e. after sunburn  [34] . It has been 
shown to activate the epidermal growth 
factor receptor and increase proliferation 
of melanoma but not of normal melano-
cytes  [35] .
 IL-8 can be produced by melanocytes 
and melanoma  [36] . IL-8-antisense oligo-
nucleotides can inhibit cell proliferation, 
arguing for the stimulatory role of IL-8 for 
cell proliferation  [36] . Interestingly, IL-6, 
another proinflammatory cytokine, in-
hibits melanocyte proliferation  [37, 38] . 
Likewise, proinflammatory TNF-  and 
-, IL-1  and - and oncostatin M can in-
hibit melanocytic growth.
 The MAP kinase pathway has been re-
peatedly shown to have important roles for 
melanoma growth. The c-kit receptor 
bound by its ligand stem cell growth factor 
activates the microphthalmia transcrip-
tion factor via the MAP-kinase pathway. 
This leads to expression of genes that are 
crucial for melanocyte survival, migra-
tion, proliferation, differentiation and pig-
ment production  [39, 28] . The c-kit recep-
tor is expressed on the protein level in 70% 
of the nevi, while stem cell growth factor is 
expressed in only 23%. Coexpression oc-
curs more commonly in dysplastic nevi 
 [28] . The serine/threonine kinase BRAF 
(v-raf murine sarcoma viral oncogene ho-
molog B1) is often mutated not only in 
melanoma but in 86% in melanocytic nevi 
as well  [40] . This indicates that although 
BRAF probably has a role for proliferative 
melanoma, it might not be crucial for ini-
tial transformation.
 Structural and Cellular Interactions 
 Melanocytes depend on basal mem-
brane contact for survival. In contrast, ne-
vus as well as melanoma cells can survive 
without constant contact to the basal 
membrane. Upon exposure to transform-
ing growth factor   1 that they can produce 
themselves, melanocytes cultured in a col-
lagen gel downregulate the protein Bcl-2, 
which leads to apoptosis. In contrast, ne-
vus and melanoma cells are resistant to 
downregulation of Bcl-2 and therefore free 
to proliferate along 3-dimensional colla-
gen structures  [41] . Accordingly, they can 
be cultured in collagen gels.
 A possible step from melanocyte to in-
dependent growth could be UVB irradia-
tion. It has been shown that UVB exposure 
leads to internalization of integrin   6 on 
melanocytes, loosening their anchorage 
on the basal membrane  [42] . This situation 
leads to apoptosis in melanocytes. How-
ever, with additional mutations such as 
BRAF the process could be survived and 
ultimately lead to anchorage-independent 
nevocellular growth.
 Local cellular interactions can influ-
ence melanocyte growth and pigmenta-
tion. Fibroblasts can inhibit nearby mela-
nocytes by expression of dickkopf1 pro-
tein, an inhibitor of the WNT pathway. 
Thus, palmoplantar fibroblasts expressing 
dickkopf1 are responsible for reduced me-
lanocytes on our palms and soles, while 
nonpalmoplantar fibroblasts express dick-
kopf3, which does not inhibit melanocytes 
 [43] .
 Systemic Mechanisms for 
Development of Nevi 
 Besides local cellular damage due to 
sunlight, blisters, scarring processes or 
trauma, systemic immunosuppression  [44] 
as well as hormonal, myelodysplastic  [45] 
and feverish processes have also been ob-
served prior to the development of erup-
tive nevi. This phenomenon has been ex-
plained with constant immunologic fac-
tors keeping in check preexisting nevus 
cell nests  [45–48] that proliferate once im-
munity wanes due to drugs or generalized 
neoplasia. Blood-borne stimulation of pre-
existing disseminated nevus nests  [16] by 
cytokines might play an additional role.
 A recent report described development 
of eruptive melanocytic nevi due to immu-
nosuppressive agents including the TNF-  
antagonist infliximab and the T cell an-
tagonist alefacept  [47] , but also more con-
ventional immunosuppressive drugs have 
been suspected to facilitate the develop-
ment of nevi ( table 1 ).
 In the presented case, linearly arranged 
dysplastic melanocytic nevi developed af-
ter a simple skin erosion due to skiing. In 
this experiment of nature, the stimulus for 
the development of these nevi was appar-
ently reduced to a simple small trauma in 
this likely predisposed patient. Whether 
these nevi developed by enlarging subclin-
ical nevus nests or whether they were new-
ly formed remains unknown, as is current-
ly the case for all acquired melanocytic 
nevi. We conclude that in predisposed pa-
tients, the trigger for the development of 
eruptive nevi can be reduced to a simple, 
localized minor trauma as was first de-
scribed by Heinrich Köbner  [49] for the
active phase of inflammatory conditions 
such as psoriasis.
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